Skip to main content
Clinical Trials/NCT04563676
NCT04563676
Active, not recruiting
Not Applicable

Physiopathology and Sequelae of COVID-19 Infection

Centre Hospitalier Universitaire, Amiens1 site in 1 country400 target enrollmentSeptember 22, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Centre Hospitalier Universitaire, Amiens
Enrollment
400
Locations
1
Primary Endpoint
8-hour cortisol level in patients with Covid19 pneumonia
Status
Active, not recruiting
Last Updated
11 months ago

Overview

Brief Summary

The data obtained from Covid-19 infections seem to suggest that the immunogenesis of Covid-19 could in some cases be the result of immune dysregulation. On the other hand, endocrine damage is possible at the tile of Covid-19 infection (mainly thyroid,adrenal, and hypothalamus). These disorders are autoimmune or linked to degeneration.

The main objective is to assess the thyroid function (thyrotropic axis) as well as the corticotropic adrenal function of patients who have had Copvid-19 pneumonia. The secondary objectives is to describe the pathophysiological mechanisms of pulmonary and vasculothrombotic involvement of Covid-19

Registry
clinicaltrials.gov
Start Date
September 22, 2020
End Date
December 2025
Last Updated
11 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patient having a covid19 infection hospitalized at the Amiens Picardie University Hospital
  • Patient who is seen in Pneumology consultation for a respiratory assessment at 3 months of his hospitalization (between M2 and M4) to evaluate presence of respiratory sequelae
  • Patient who agreed to participate in the protocol
  • Patient affiliated to a Social Security

Exclusion Criteria

  • patient under guardianship or curators
  • patient refusing to participate

Outcomes

Primary Outcomes

8-hour cortisol level in patients with Covid19 pneumonia

Time Frame: day 0

8-hour cortisol level in patients with Covid19 pneumonia will be determined the day of consultation for respiratory sequelae.

TSH level in patients with Covid19 pneumonia

Time Frame: day 0

TSH level in patients with Covid19 pneumonia will be determined the day of consultation for respiratory sequelae.

Study Sites (1)

Loading locations...

Similar Trials